Sensei Biotherapeutics Inc (SNSE) Stock Analysis

Sensei Biotherapeutics Inc (SNSE) is a publicly traded company in the HEALTHCARE sector. It trades at $16.09, carries a market capitalization of $28.37M. This page summarizes the public market data, fundamentals, and frequently asked questions for SNSE, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Sensei Biotherapeutics Inc currently has a Neutral sentiment score of -0.03.

About Sensei Biotherapeutics Inc

Sensei Biotherapeutics, Inc. is a clinical-stage immunotherapy company based in Rockville, Maryland, committed to pioneering innovative therapies designed to combat cancer. By harnessing advanced scientific approaches, Sensei aims to develop novel treatments that engage the immune system to fight tumors effectively. With a robust pipeline and a focus on the intersection of biotechnology and patient care, the company is positioned to make significant contributions to the evolving landscape of ...

GNG Research Analysis

GNG Research scores Sensei Biotherapeutics Inc (SNSE) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for SNSE.

Frequently Asked Questions

Does SNSE pay dividends?

Sensei Biotherapeutics Inc (SNSE) does not currently pay a regular dividend.

What is SNSE's market cap?

Sensei Biotherapeutics Inc (SNSE) has a market capitalization of $28.37M with a current stock price of $16.09.